Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acceleron Pharma Inc (NASDAQ:XLRN)

25.03
Delayed Data
As of 12:44pm ET
 -0.50 / -1.96%
Today’s Change
22.67
Today|||52-Week Range
41.69
-1.92%
Year-to-Date
No recent news for Acceleron Pharma Inc.

Today’s Trading

Previous close25.53
Today’s open25.29
Day’s range24.81 - 25.52
Volume167,753
Average volume (3 months)375,100
Market cap$963.7M
Dividend yield--
Data as of 12:44pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-17.71%
Earnings growth (this year)+15.53%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+23.68%
P/E ratioNM
Price/Sales89.73
Price/Book7.78

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-0.55-1.69%
CRSPCRISPR Therapeutics ...+0.51+2.41%
AMAGAMAG Pharmaceuticals...+0.45+1.96%
MNTAMomenta Pharmaceutic...-0.70-4.35%
Data as of 12:59pm ET, 01/17/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$18.1M
Annual profit (last year)-$63.9M
Net profit margin-353.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Habib J. Dable
Chief Operating Officer &
Executive Vice President
Steven D. Ertel
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs